2025
The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse Outcomes
Wen Y, Srialluri N, Farrington D, Thiessen-Philbrook H, Menez S, Moledina D, Coca S, Ikizler T, Siew E, Go A, Hsu C, Himmelfarb J, Chinchilli V, Kaufman J, Kimmel P, Garg A, Grams M, Parikh C. The Discrepancy Between Estimated GFR Cystatin C and Estimated GFR Creatinine at 3 Months After Hospitalization and Long-Term Adverse Outcomes. Kidney International Reports 2025, 10: 1896-1906. DOI: 10.1016/j.ekir.2025.04.003.Peer-Reviewed Original ResearchAcute kidney injuryEnd-stage kidney diseaseHeart failure hospitalizationFailure hospitalizationCystatin CHospitalized adultsRisk of heart failure hospitalizationHigher risk of heart failure hospitalizationLong-term adverse outcomesMedian Follow-UpRisk of end-stage kidney diseaseAge of study participantsPrognostic valuePrognostic markerCardiac eventsKidney injuryRisk stratificationFollow-upAdverse outcomesKidney diseaseEGFRcrHospitalized patientsHigh riskSurvival analysisEGFRcysIntervention for hospitalized people with chronic pain and elevated risk for opioid‐related harm: A pilot randomized controlled trial
Weimer M, Buonora M, Hajduk A, Ackerman A, Daggula K, Becker W, Chaudhry S, Fiellin D. Intervention for hospitalized people with chronic pain and elevated risk for opioid‐related harm: A pilot randomized controlled trial. Journal Of Hospital Medicine 2025 PMID: 40271961, DOI: 10.1002/jhm.70066.Peer-Reviewed Original ResearchOpioid-related harmsGuideline-concordant carePain interventionsCase identification toolElevated riskChronic painOpioid stewardshipHospitalized peopleEMR-based toolOpioid stewardship programsPain-related careRandomized Controlled TrialsUsual carePotential participantsCareManagement of analgesiaExploratory outcomesControlled TrialsPrimary outcomeHospitalized adultsInterventionHarmPainNo significant differenceRiskP-2008. Chronic Conditions as Risk Factors for COVID-19–Associated Hospitalization Among Adults, 2022-2023
Hamid S, Derado G, Pham H, Woodruff R, Sachdev D, Kawasaki B, Meek J, Witt L, Ryan P, Kim S, Bye E, Akpo J, Rowlands J, Licherdell E, Shiltz E, Sutton M, Talbot K, Price A, Havers F, Taylor C. P-2008. Chronic Conditions as Risk Factors for COVID-19–Associated Hospitalization Among Adults, 2022-2023. Open Forum Infectious Diseases 2025, 12: ofae631.2165. PMCID: PMC11777768, DOI: 10.1093/ofid/ofae631.2165.Peer-Reviewed Original ResearchChronic conditionsHospitalization ratesRisk factorsBehavioral Risk Factor Surveillance SystemRate ratiosRisk Factor Surveillance SystemPopulation-based active surveillance systemCOVID-19-associated hospitalizationSurveillance systemCounty-level population dataOlder ageAge groupsAssociated with increased riskHistory of strokeCouncil of StateCOVID-19-Associated Hospitalization Surveillance NetworkPoisson regressionRate denominatorCatchment areaActive surveillance systemAnalytic populationConfidence intervalsAdult populationHospitalization countsHospitalized adults
2024
A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infections
Dunne M, Aronin S, Das A, Akinapelli K, Breen J, Zelasky M, Puttagunta S. A phase 3 randomized trial of sulopenem vs. ertapenem in patients with complicated intra-abdominal infections. Clinical Microbiology And Infection 2024, 31: 396-401. PMID: 39491784, DOI: 10.1016/j.cmi.2024.10.025.Peer-Reviewed Original ResearchComplicated intraabdominal infectionsIntraabdominal infectionsPhase 3 randomized trialErtapenem-treated patientsClinical success rateRandomized to 5Confidence intervalsNon-inferiority marginOral regimensAmoxicillin-clavulanateClinical responsePrimary endpointTreatment armsIsolated pathogensTreatment durationHospitalized adultsErtapenemB. fragilisPatientsSuccess rateSulopenemInfectionEndpointTreatment differencesDaysDevelopment of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis
Chan C, Minahan-Rowley R, Biegacki E, Sue K, Weimer M. Development of a Patient and Clinician Informed Website on Injection Drug Use Related Infective Endocarditis. Substance Abuse 2024, 46: 280-290. PMID: 39087514, DOI: 10.1177/29767342241267077.Peer-Reviewed Original ResearchInjection drug use-related infective endocarditisSemi-structured interviewsInjection drug usePatient participationPatient websitesInjection practicesInfective endocarditisPatient education resourcesHelpfulness of informationHistory of injection drug useDrug useMixed-methods studyHealthcare cliniciansBaseline surveyOpioid use disorderPrevention strategiesInformation websitesEducational materialsCounseling patientsHospitalized adultsPromote educationWebsite sectionsCliniciansSurvey feedbackUse disorderAcute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection
Woodruff R, Melgar M, Pham H, Sperling L, Loustalot F, Kirley P, Austin E, Yousey-Hindes K, Openo K, Ryan P, Brown C, Lynfield R, Davis S, Barney G, Tesini B, Sutton M, Talbot H, Zahid H, Kim L, Havers F, Rowlands J, Spina N, Engesser K, Salazar-Sanchez Y, George A, Staten H, Bleecker M, Leegwater L, Tellez Nunez V, Falkowski A, Felsen C, Licherdell E, St George K, Pacheco F, Desiato J, Labozzo N, Zmek E, Alden N, Strayhorn N, Fawcett E, Surell C, Como-Sabetti K, Mumm E, Bilski K, Markus T, Ndi D, Billings K. Acute Cardiac Events in Hospitalized Older Adults With Respiratory Syncytial Virus Infection. JAMA Internal Medicine 2024, 184: 602-611. PMID: 38619857, PMCID: PMC11019447, DOI: 10.1001/jamainternmed.2024.0212.Peer-Reviewed Original ResearchRespiratory syncytial virus infectionRespiratory syncytial virusRespiratory syncytial virus seasonAcute cardiac eventsCardiac eventsWeighted estimated prevalenceIn-Hospital DeathAdjusted risk ratiosIntensive care unitClassification of diseasesCross-sectional studyHospitalized adultsCardiac complicationsRSV infectionRSV diseaseLaboratory-confirmed RSV infectionOlder adultsCases of RSV infectionReceipt of invasive mechanical ventilationCardiovascular diseaseIntensive care unit admissionSevere outcomesEstimated prevalenceAcute heart failurePotential cardiac complicationsDiagnostic Errors in Hospitalized Adults Who Died or Were Transferred to Intensive Care
Auerbach A, Lee T, Hubbard C, Ranji S, Raffel K, Valdes G, Boscardin J, Dalal A, Harris A, Flynn E, Schnipper J, Feinbloom D, Roy B, Herzig S, Wazir M, Gershanik E, Goyal A, Chitneni P, Burney S, Galinsky J, Rastegar S, Moore D, Berdahl C, Seferian E, Suri K, Ramishvili T, Vedamurthy D, Hunt D, Mehta A, Katakam H, Field S, Karatasakis B, Beeler K, Himmel A, Eid S, Gandhi S, Pena I, Ranta Z, Lipten S, Lucier D, Walker-Corkery B, Kleinman Sween J, Kirchoff R, Rieck K, Kolar G, Parikh R, Burton C, Dugani C, Dapaah-Afriyie K, Finn A, Raju S, Surani A, Segon A, Bhandari S, Astik G, O’Leary K, Helminski A, Anstey J, Zhou M, Alday A, Halvorson S, Esmaili A, Barish P, Fenton C, Kantor M, Choi K, Schram A, Ruhnke G, Patel H, Virapongse A, Burden M, Ngov L, Keniston A, Talari P, Romond J, Vick S, Williams M, Marr R, Gupta A, Rohde J, Mao F, Fang M, Greysen S, Shah P, Kim C, Narayanan M, Wolpaw B, Ellingson S, Kaiksow F, Kenik J, Sterken D, Lewis M, Manwani B, Ledford R, Webber C, Vasilevskis E, Buckley R, Kripalani S, Sankey C, Ostfeld-Johns S, Gielissen K, Wijesekera T, Jordan E, Karwa A, Churnet B, Chia D, Brooks K. Diagnostic Errors in Hospitalized Adults Who Died or Were Transferred to Intensive Care. JAMA Internal Medicine 2024, 184: 164-173. PMID: 38190122, PMCID: PMC10775080, DOI: 10.1001/jamainternmed.2023.7347.Peer-Reviewed Original ResearchConceptsPatient harmIntensive care unitHospitalized adultsDiagnostic errorsAssociated with patient harmCohort studyMultivariate modelRandom sample of adultsAcademic medical centerSample of adultsDiagnostic error reductionTemporary harmGeneral medical conditionsAttributable fractionRetrospective cohort studyMain OutcomesMedical inpatientsTest orderingPermanent harmTrained cliniciansImprovement effortsMedical conditionsClinician assessmentMedical CenterPatient records
2023
2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023
DeCuir J, Zhu Y, Gaglani M, Ginde A, Mohr N, Gibbs K, Hager D, Frosch A, Mohamed A, Johnson N, Steingrub J, Peltan I, Martin E, Bender W, Wilson J, Qadir N, Mallow C, Kwon J, Exline M, Lauring A, Columbus C, Vaughn I, Safdar B, Chappell J, Baughman A, Womack K, Swan S, McMorrow M, Self W, Surie D. 2083. Waning of Bivalent mRNA Vaccine Effectiveness Against COVID-19-associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years – IVY Network, 20 U.S. States, September 8, 2022-April 1, 2023. Open Forum Infectious Diseases 2023, 10: ofad500.153. PMCID: PMC10677158, DOI: 10.1093/ofid/ofad500.153.Peer-Reviewed Original ResearchCOVID-19-associated hospitalizationRelative vaccine effectivenessVaccine effectivenessBooster doseSARS-CoV-2Hospitalized adultsIllness onsetDays of receiptCOVID-19 vaccination seriesCOVID-19-like illnessAdditional booster dosesAsahi Kasei PharmaMRNA vaccine effectivenessMultivariable logistic regressionHuman Services (HHS) regionsCase-control analysisUnvaccinated patientsVaccination seriesBooster dosesImmunization PracticesMRNA vaccinationAdults AgedRespiratory virusesAntigen testAdmission dateA randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes
Wilson F, Yamamoto Y, Martin M, Coronel-Moreno C, Li F, Cheng C, Aklilu A, Ghazi L, Greenberg J, Latham S, Melchinger H, Mansour S, Moledina D, Parikh C, Partridge C, Testani J, Ugwuowo U. A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes. Nature Communications 2023, 14: 2826. PMID: 37198160, PMCID: PMC10192367, DOI: 10.1038/s41467-023-38532-3.Peer-Reviewed Original ResearchConceptsAcute kidney injuryUsual care groupKidney injuryCare groupAcute Kidney Injury OutcomesAlert groupNon-steroidal anti-inflammatory drugsComposite of progressionHours of randomizationMedications of interestAldosterone system inhibitorsClasses of medicationsProton pump inhibitorsRandomized clinical trialsAnti-inflammatory drugsClinical decision support systemNephrotoxic medicationsHospitalized adultsDiscontinuation ratesCertain medicationsPrimary outcomeSubstantial morbiditySystem inhibitorsPump inhibitorsParallel groupBacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022
Shah M, Patel K, Milucky J, Taylor C, Reingold A, Armistead I, Meek J, Anderson E, Weigel A, Reeg L, Como‐Sabetti K, Ropp S, Muse A, Bushey S, Shiltz E, Sutton M, Talbot H, Chatelain R, Havers F, Team T. Bacterial and viral infections among adults hospitalized with COVID‐19, COVID‐NET, 14 states, March 2020–April 2022. Influenza And Other Respiratory Viruses 2023, 17: e13107. PMID: 36875205, PMCID: PMC9981874, DOI: 10.1111/irv.13107.Peer-Reviewed Original ResearchConceptsDay of admissionSARS-CoV-2 infectionHospitalized adultsViral infectionBacterial coinfectionCOVID-19Laboratory-confirmed SARS-CoV-2 infectionBacterial infectionsPopulation-based surveillance systemRhinovirus/enterovirusRespiratory syncytial virusBacterial pathogensCoV-2 virusClinical featuresClinical outcomesViral coinfectionSyncytial virusHuman metapneumovirusParainfluenza virusRisk factorsSterile sitesEndemic coronavirusesRelative riskRelevant bacterial pathogensGram-negative rods
2022
303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020–February 2022
Melisa S, Taylor C, Patel K, Milucky J, Whitaker M, Pham H, Anglin O, Reingold A, Armistead I, Yousey-Hindes K, Anderson E, Weigel A, Reeg L, Mumm E, Ropp S, Muse A, Bushey S, Shiltz E, Sutton M, Talbot K, Price A, Havers F. 303. Viral and bacterial infections among adults hospitalized with COVID-19, Coronavirus Disease 2019-Associated Hospitalization Surveillance Network, 14 states, March 2020–February 2022. Open Forum Infectious Diseases 2022, 9: ofac492.381. PMCID: PMC9751616, DOI: 10.1093/ofid/ofac492.381.Peer-Reviewed Original ResearchDay of admissionBacterial infectionsCoronavirus diseaseRelevant bacterial pathogensCOVID-19Acute respiratory syndrome coronavirus 2 infectionLaboratory-confirmed SARS-CoV-2 infectionSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectionSyndrome coronavirus 2 infectionSARS-CoV-2 infectionSurveillance networkCommon respiratory isolatesRV/EVCoronavirus 2 infectionRhinovirus/enterovirusBronchoalveolar lavage fluidRespiratory syncytial virusBacterial pathogensCare molecular testingHospitalized adultsBacterial coinfectionClinical featuresClinical outcomesLavage fluidSyncytial virusManagement of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine
Calcaterra SL, Martin M, Bottner R, Englander H, Weinstein Z, Weimer MB, Lambert E, Herzig SJ. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. Journal Of Hospital Medicine 2022, 17: 744-756. PMID: 35880813, PMCID: PMC9474708, DOI: 10.1002/jhm.12893.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsOpioid use disorderConsensus statementHospitalized adultsOpioid withdrawalUse disordersTreatment of OUDDraft statementManagement of OUDHospital medicineAcute pain managementNumber of hospitalizationsHospital-based cliniciansFinal consensus statementOpioid-related overdoseHospital dischargeOpioid usePain managementWorking GroupCare transitionsInpatient settingObservational studyExpert consensusGuidance statementsPatientsSystematic reviewManagement of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines
Calcaterra SL, Bottner R, Martin M, Englander H, Weinstein ZM, Weimer MB, Lambert E, Ronan MV, Huerta S, Zaman T, Ullal M, Peterkin AF, Torres‐Lockhart K, Buresh M, O'Brien MT, Snyder H, Herzig SJ. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. Journal Of Hospital Medicine 2022, 17: 679-692. PMID: 35880821, PMCID: PMC9474657, DOI: 10.1002/jhm.12908.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsOpioid overdose preventionOpioid withdrawalOpioid useOUD treatmentOverdose preventionShort-acting opioid analgesicsOpioid use disorder managementAcute pain managementUse of methadoneOpioid use disorderEvaluation II (AGREE II) instrumentAppraisal of GuidelinesOpioid withdrawal managementUse of multimodalOpioid overdose reversalMethadone initiationNonopioid therapyHospitalized adultsBuprenorphine treatmentOpioid analgesicsPain managementTreatment guidelinesDiagnostic Statistical ManualOvid MEDLINEEdition criteriaRates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes—Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2017
Owusu D, Rolfes M, Arriola C, Kirley P, Alden N, Meek J, Anderson E, Monroe M, Kim S, Lynfield R, Angeles K, Spina N, Felsen C, Billing L, Thomas A, Talbot H, Schaffner W, Chatelain R, Reed C, Garg S. Rates of Severe Influenza-Associated Outcomes Among Older Adults Living With Diabetes—Influenza Hospitalization Surveillance Network (FluSurv-NET), 2012–2017. Open Forum Infectious Diseases 2022, 9: ofac131. PMID: 35450083, PMCID: PMC9017364, DOI: 10.1093/ofid/ofac131.Peer-Reviewed Original ResearchInfluenza-associated outcomesInfluenza-associated hospitalizationsDiabetes mellitusOlder adultsHospital deathMechanical ventilationRate ratioLaboratory-confirmed influenza-associated hospitalizationsInfluenza Hospitalization Surveillance NetworkIntensive care unit admissionImpact of DMPopulation-based surveillance systemStatistics population dataCare unit admissionInfluenza virus infectionConfidence intervalsHigh rateUnit admissionHospitalized adultsICU admissionInfluenza illnessPooled rateAnnual vaccinationEarly treatmentVirus infectionSevere inpatient hypertension prevalence and blood pressure response to antihypertensive treatment
Ghazi L, Li F, Chen X, Simonov M, Yamamoto Y, Biswas A, Hanna J, Shah T, Townsend R, Peixoto A, Wilson FP. Severe inpatient hypertension prevalence and blood pressure response to antihypertensive treatment. Journal Of Clinical Hypertension 2022, 24: 339-349. PMID: 35174627, PMCID: PMC8925013, DOI: 10.1111/jch.14431.Peer-Reviewed Original ResearchConceptsSevere hypertensionBlood pressure responseBP elevationUntreated patientsCox proportional hazards modelRetrospective cohort studyPressure responseProportional hazards modelAntihypertensive treatmentInpatient hypertensionMore comorbiditiesPossible overtreatmentHospitalized adultsCohort studyHypertension prevalenceArterial pressureHospitalized patientsTreatment guidelinesHypertensionGreater rateHazards modelPatientsAntihypertensivesTreatmentAdmission
2021
Changes in Pediatric Hospital Care during the COVID‐19 Pandemic: A National Qualitative Study
Penwill N, De Angulo N, Elster M, Pathak P, Ja C, Hochreiter D, Wilson K, Newton J, Kaiser S. Changes in Pediatric Hospital Care during the COVID‐19 Pandemic: A National Qualitative Study. Health Services Research 2021, 56: 50-51. PMCID: PMC8441372, DOI: 10.1111/1475-6773.13818.Peer-Reviewed Original ResearchClinician mental healthCOVID-19 patientsHospitalized adultsAdult hospitalistsMental healthPediatric patientsChildren's HospitalHospitalized childrenHospital policiesCOVID-19 pandemicHospital leadersCOVID-19 hospitalization ratesCOVID-19 patient careMultisystem inflammatory syndromePediatric hospital careHealthcare deliveryHigh-quality careMental health resourcesPediatric care deliveryPersonal protective equipmentNational qualitative studyInflammatory syndromeReferral centerMedical managementHospitalization ratesClinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020
Garg S, Patel K, Pham H, Whitaker M, O'Halloran A, Milucky J, Anglin O, Kirley PD, Reingold A, Kawasaki B, Herlihy R, Yousey-Hindes K, Maslar A, Anderson EJ, Openo KP, Weigel A, Teno K, Ryan PA, Monroe ML, Reeg L, Kim S, Como-Sabetti K, Bye E, Davis S, Eisenberg N, Muse A, Barney G, Bennett NM, Felsen CB, Billing L, Shiltz J, Sutton M, Abdullah N, Talbot HK, Schaffner W, Hill M, Chatelain R, Wortham J, Taylor C, Hall A, Fry AM, Kim L, Havers FP. Clinical Trends Among U.S. Adults Hospitalized With COVID-19, March to December 2020. Annals Of Internal Medicine 2021, 174: m21-1991. PMID: 34370517, PMCID: PMC8381761, DOI: 10.7326/m21-1991.Peer-Reviewed Original ResearchMeSH KeywordsAdenosine MonophosphateAdolescentAdrenal Cortex HormonesAdultAge DistributionAgedAlanineAntiviral AgentsCOVID-19Critical CareCross-Sectional StudiesFemaleHospitalizationHumansIntensive Care UnitsLength of StayMaleMiddle AgedPandemicsRespiration, ArtificialSARS-CoV-2United StatesVasoconstrictor AgentsYoung AdultConceptsICU admissionClinical trendsMechanical ventilationCOVID-19COVID-19-associated hospitalizationIntensive care unit admissionLaboratory-confirmed COVID-19U.S. adultsNon-Hispanic black personsCare unit admissionHospital death rateNoninvasive respiratory supportUse of remdesivirPercentage of interventionsCross-sectional studyCOVID-19 vaccineNon-Hispanic whitesSystemic corticosteroidsUnit admissionVasopressor useHospitalized adultsRespiratory supportCase patientsMedian ageSubstantial morbidity
2020
520. Longitudinal Analysis of SARS-CoV-2 Viruses in Hospitalized Adults
Simons L, Lorenzo-Redondo R, Nam H, Roberts S, Ison M, Achenbach C, Hauser A, Ozer E, Hultquist J. 520. Longitudinal Analysis of SARS-CoV-2 Viruses in Hospitalized Adults. Open Forum Infectious Diseases 2020, 7: s325-s326. PMCID: PMC7776408, DOI: 10.1093/ofid/ofaa439.714.Peer-Reviewed Original ResearchSARS-CoV-2 viral loadViral loadSARS-CoV-2Hospitalized adultsPositive SARS-CoV-2 testSARS-CoV-2 testWhole viral genome sequencingNasopharyngeal viral loadResults 60 patientsNorthwestern Memorial HospitalCoronavirus disease 2019Viral load dataSARS-CoV-2 virusImmune selective pressureViral genome sequencingQuantitative reverse transcriptase PCRReverse transcriptase-PCRNasopharyngeal specimensNasopharyngeal swabsMemorial HospitalClinical dataIndividual patientsClinical consequencesDisease 2019Immune pressureA Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City
Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A, Morgan N, Patel P, Gutman J, Melmed K, Agarwal S, Bokhari M, Andino A, Valdes E, Omari M, Kvernland A, Lillemoe K, Chou SH, McNett M, Helbok R, Mainali S, Fink EL, Robertson C, Schober M, Suarez JI, Ziai W, Menon D, Friedman D, Friedman D, Holmes M, Huang J, Thawani S, Howard J, Abou-Fayssal N, Krieger P, Lewis A, Lord AS, Zhou T, Kahn DE, Czeisler BM, Torres J, Yaghi S, Ishida K, Scher E, de Havenon A, Placantonakis D, Liu M, Wisniewski T, Troxel AB, Balcer L, Galetta S. A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City. Neurology 2020, 96: 10.1212/wnl.0000000000010979. PMID: 33020166, PMCID: PMC7905791, DOI: 10.1212/wnl.0000000000010979.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge FactorsAgedBrain DiseasesCOVID-19FemaleHospital MortalityHospitalizationHumansIntubation, IntratrachealMaleMiddle AgedNervous System DiseasesNeurotoxicity SyndromesNew York CityOrgan Dysfunction ScoresPatient DischargeProspective StudiesSex FactorsSpinal Cord DiseasesYoung AdultConceptsNew neurologic disordersSARS-CoV-2 infectionLikelihood of dischargeNeurologic disordersHospital mortalityHigher Sequential Organ Failure Assessment scoreLaboratory-confirmed SARS-CoV-2 infectionSequential Organ Failure Assessment scoreCOVID-19Severe acute respiratory syndrome coronavirus 2Organ Failure Assessment scoreAcute respiratory syndrome coronavirus 2Hospitalized COVID-19 patientsHypoxic/ischemic injuryCOVID-19 symptom onsetRespiratory syndrome coronavirus 2Meningitis/encephalitisSevere systemic illnessCOVID-19 patientsSyndrome coronavirus 2Coronavirus disease 2019SARS-CoV-2SOFA scoreHospital outcomesHospitalized adultsConverging Crises: Caring for Hospitalized Adults With Substance Use Disorder in the Time of COVID‐19
Englander H, Salisbury‐Afshar E, Gregg J, Martin M, Snyder H, Weinstein Z, King C. Converging Crises: Caring for Hospitalized Adults With Substance Use Disorder in the Time of COVID‐19. Journal Of Hospital Medicine 2020, 15: 628-630. PMID: 32966196, PMCID: PMC7531943, DOI: 10.12788/jhm.3485.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply